Stephen H. Norris

机构：Bristol-Myers Squibb (United States) · ORCID：0009-0009-7323-4629

发表论文 46 篇 · 总被引 2030 次 · h-index 17

代表论文

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial (2015 · The Lancet · 被引 318)
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran (2015 · Thrombosis and Haemostasis · 被引 245)
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study (2016 · Clinical Pharmacokinetics · 被引 88)
Idarucizumab, a Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Elderly and Renally Impaired Subjects (2014 · Blood · 被引 70)
Pharmacokinetic Characterization of Different Dose Combinations of Coadministered Tipranavir and Ritonavir in Healthy Volunteers (2004 · HIV Clinical Trials · 被引 64)
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation (2023 · Journal of Medicinal Chemistry · 被引 53)